JOHNATHAN SALVI: Open Payments
NPI 1134874589 · ALGONQUIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,180 in 189 payments from 24 companies in 2025. Trend: 2023 $3,217 · 2024 $4,249 · 2025 $4,180
Food & beverage: $4,180
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $415 |
| Corcept Therapeutics | 10 | $353 |
| Novo Nordisk Inc | 14 | $351 |
| ABBVIE INC. | 17 | $331 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $322 |
| PFIZER INC. | 15 | $272 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $255 |
| Lilly USA, LLC | 10 | $231 |
| Lundbeck LLC | 10 | $196 |
| Otsuka America Pharmaceutical, Inc. | 8 | $189 |
Products named: JARDIANCE, REXULTI, Korlym, CAPLYTA, VRAYLAR, FARXIGA, QULIPTA, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
